Flora Expands Presence into EU; Signs LOI to Become Long-Term Strategic Partner to Hoshi International
June 7th, 2021
- Hoshi’s infrastructure will serve as a gateway for distribution of Flora’s Colombian Cannabis and product portfolio into the European Union (“EU”)
- Hoshi’s experienced leadership team and global distribution network to serve as a catalyst for revenue growth for Flora’s operating divisions
- Flora’s proposed initial equity Investment of € 2M (two-million Euros) to accelerate expansion projects in Portugal and Malta
TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that the Company has signed a Letter of Intent (“LOI”) for the purpose of making an initial strategic equity investment of €2M (two-million Euros) into the European cannabis company, Hoshi International Inc. (“Hoshi”).
“This initial investment into Hoshi is the first of many steps by Flora to advance its plans to launch Flora-branded products across the world,” said Luis Merchan, CEO of Flora. “We believe in backing strong teams with proven track records and creating synergistic relationships where core competencies have minimal overlap. The Hoshi team has built a fantastic base in Europe and by utilizing our low-cost, high-potency product and established brands, it allows both of our organizations to have a competitive edge as the European cannabis market continues to grow rapidly.”
Hoshi is positioned to become a leading vertically integrated medical cannabis company in Europe. Hoshi was founded by a group of cannabis entrepreneurs who have built and scaled several cannabis businesses in the highly regulated cannabis market in Canada. Flora’s proposed investment into Hoshi will establish Flora as a preferred strategic supplier to Hoshi’s two EU processing facilities, located in Malta and Portugal.
Hoshi, through its wholly-owned subsidiary, has entered into a letter of intent with Malta Enterprise, the economic development agency for the Republic of Malta, a member of the European Union, to import, process, produce and distribute finished cannabis and cannabis derivatives products (the “License”). The formal License is expected to be issued by the Maltese Medicines Authority upon inspection and completion of the EU-GMP compliant cannabis processing facility. Additionally, Hoshi has been awarded a conditional license for cultivation and processing in Portugal for both greenhouse and outdoor production.
“We believe this strategic partnership will provide Flora with a manufacturing footprint in the EU that allows us to build and distribute Flora-branded products to its customers in the EU, while also providing a port for the importation of compliant, high-quality, Colombian outdoor cannabis flower, and derivatives,” said James Williams, VP of Corporate Development for Flora.
This strategic investment, anticipated to close by mid June, is expected to further enhance Flora’s ability to capitalize on the rapidly evolving European cannabis markets, providing additional distribution opportunities for Flora’s portfolio of internationally registered and recognized cannabis-based products. Flora anticipates leveraging Hoshi’s experienced team and deep knowledge of global medical and recreational markets as it explores further opportunities to expand production and distribution capabilities.
“A partnership with Flora will enable Hoshi to fast track a number of established initiatives to sell high-quality GACP flower to the EU market,” said John B. Aird, CEO of Hoshi. “We look forward to working with the Flora team and accessing not only their high-end genetics and outdoor-grown cannabis, but also assisting Flora to distribute more finished products to customers across the EU.”
Strategic Highlights of the Investment
- Strategic partnership with a company that holds European assets, providing Flora with a pathway to European distribution with the introduction of Flora’s products, formulations, and brands.
- Alignment between two strong management teams. Hoshi’s management team has extensive entrepreneurial and leadership experience in the global cannabis market.
- Leveraging Hoshi’s various distribution agreements throughout the European Union, including the United Kingdom, Germany, and Poland. Additional distribution agreements are being actively pursued and negotiated.
About Hoshi International Inc.
Hoshi is a European focused, fully integrated medical cannabis company led by a team of renowned cannabis entrepreneurs. Hoshi is focused on developing and operationalizing assets across the global cannabis industry with an emphasis on cultivating, manufacturing, and distributing cannabis derived products. Hoshi is uniquely positioned to be a leading provider of cannabis and derivative products for the emerging European market.
About Flora Growth Corp.
Flora is a cannabis company that will leverage natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.floragrowth.ca or follow @floragrowthcorp on social for more information.
Investor Relations Contact:
+1 416 571 9037
Public Relations Contact:
+1 (847) 271-3443
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: the ability to complete the Hoshi investment and the timing thereof; the future relationship between the Company and Hoshi; our expansion plans; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.